Trials / Completed
CompletedNCT06206811
Phase 1 Study to Investigate OD-07656 in Healthy Adult Participants
A Four-part, Phase 1, Double-blind Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) with Single and Multiple Ascending Oral Doses of OD-07656 in Healthy, Adult Male and Female Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 101 (actual)
- Sponsor
- Odyssey Therapeutics · Industry
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
First-in-human study to provide an assessment of the safety, tolerability, pharmacokinetics (PK), including food effects and a drug-drug interaction, and pharmacodynamics (PD) of OD-07656 after administration of ascending single and multiple oral doses to healthy male and female participants in view of treating inflammatory bowel disease (IBD) (including Crohn's disease and ulcerative colitis), Blau syndrome, and spondyloarthritis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | OD-07656 | innate immune modulator |
Timeline
- Start date
- 2024-02-12
- Primary completion
- 2024-11-25
- Completion
- 2024-11-25
- First posted
- 2024-01-16
- Last updated
- 2025-02-21
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT06206811. Inclusion in this directory is not an endorsement.